Memantine prolongs survival in an amyotrophic lateral sclerosis mouse model

European Journal of Neuroscience

Volumn 22, Issue 9, 2005, Pages 2376-2380

  Wang, Rengang ^a   Zhang, Dongxian ^a  

^a BURNHAM INSTITUTE   (United States)

Author keywords

G93A; N methyl D aspartate receptor; Spinal cord; Superoxide dismutase

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; RECEPTOR SUBUNIT;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE MODEL; DRUG EFFICACY; LIFESPAN; MALE; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RECEPTOR BLOCKING; RELIABILITY; SPINAL CORD; SURVIVAL; WILD TYPE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; DISEASE MODELS, ANIMAL; EXCITATORY AMINO ACID ANTAGONISTS; GENE EXPRESSION REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; MEMANTINE; MICE; MICE, TRANSGENIC; RECEPTORS, N-METHYL-D-ASPARTATE; SPINAL CORD; SUPEROXIDE DISMUTASE; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 27844479654     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2005.04431.x     Document Type: Article

References (40)

1. Abdrachmanova, G., Teisinger, J., Vlachova, V. & Vyklicky, L. Jr (2000) Molecular and functional properties of synaptically activated NMDA receptors in neonatal motoneurons in rat spinal cord slices. Eur. J. Neurosci., 12, 955-963.
2. Alessandri, B. & Bullock, R. (1998) Glutamate and its receptors in the pathophysiology of brain and spinal cord injuries. Prog. Brain Res., 116, 303-330.
3. Bendotti, C. & Carri, M.T. (2004) Lessons from models of SOD1-linked familial ALS. Trends Mol. Med., 10, 393-400.
4. Bensimon, G., Lacomblez, L. & Meininger, V. (1994) A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group. N. Engl. J. Med., 330, 585-591.
5. Blin, O., Azulay, J.P., Desnuelle, C., Bille-Turc, F., Braguer, D., Besse, D., Branger, E., Crevat, A., Serratrice, G. & Pouget, J.Y. (1996) A controlled one-year trial of dextromethorphan in amyotrophic lateral sclerosis. Clin. Neuropharmacol., 19, 182-192.
6. Boyce, S., Webb, J.K., Carlson, E., Rupniak, N.M., Hill, R.G. & Martin, J.E. (1999) Onset and progression of motor deficits in motor neuron degeneration (mnd) mice are unaltered by the glycine/NMDA receptor antagonist L-701,324 or the MAO-B inhibitor R(-)-deprenyl. Exp. Neurol., 155, 49-58.
7. Bruijn, L.I., Becher, M.W., Lee, M.K., Anderson, K.L., Jenkins, N.A., Copeland, N.G., Sisodia, S.S., Rothstein, J.D., Borchelt, D.R., Price, D.L. & Cleveland, D.W. (1997) ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron, 18, 327-338.
8. Bruijn, L.I., Miller, T.M. & Cleveland, D.W. (2004) Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu. Rev. Neurosci., 27, 723-749.
9. Carriedo, S.G., Yin, H.Z. & Weiss, J.H. (1996) Motor neurons are selectively vulnerable to AMPA/kainate receptor-mediated injury in vitro. J. Neurosci., 16, 4069-4079.
10. Chen, H.S. & Lipton, S.A. (1997) Mechanism of memantine block of NMDA-activated channels in rat retinal ganglion cells: uncompetitive antagonism. J. Physiol (Lond.), 499, 27-46.
11. Chen, H.S., Pellegrini, J.W., Aggarwal, S.K., Lei, S.Z., Warach, S., Jensen, F.E. & Lipton, S.A. (1992) Open-channel block of N-methyl-D-aspartate (NMDA) responses by memantine: therapeutic advantage against NMDA receptor-mediated neurotoxicity. J. Neurosci., 12, 4427-4436.
12. Erdo, S.L. & Schafer, M. (1991) Memantine is highly potent in protecting cortical cultures against excitotoxic cell death evoked by glutamate and N-methyl-D-aspartate. Eur. J. Pharmacol, 198, 215-217.
13. Estevez, A.G., Stutzmann, J.M. & Barbeito, L. (1995) Protective effect of riluzole on excitatory amino acid-mediated neurotoxicity in motoneuron-enriched cultures. Eur. J. Pharmacol., 280, 47-53.
14. Gredal, O., Werdelin, L., Bak, S., Christensen, P.B., Boysen, G., Kristensen, M.O., Jespersen, J.H., Regeur, L., Hinge, H.H. & Jensen, T.S. (1997) A clinical trial of dextromethorphan in amyotrophic lateral sclerosis. Acta Neurol. Scand., 96, 8-13.
15. Gurney, M.E., Cutting, F.B., Zhai, P., Doble, A., Taylor, C.P., Andrus, P.K. & Hall, E.D. (1996) Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis. Ann. Neurol., 39, 147-157.
16. Gurney, M.E., Pu, H., Chiu, A.Y., Dal Canto, M.C., Polchow, C.Y., Alexander, D.D., Caliendo, J., Hentati, A., Kwon, Y.W. & Deng, H.X. (1994) Motor neuron degeneration in mice that express a human Cu,Zn Superoxide dismutase mutation. Science, 264, 1772-1775.
17. Hori, Y. & Kanda, K. (1996) Developmental alterations in NMDA receptor-mediated currents in neonatal rat spinal motoneurons. Neurosci. Lett., 205, 99-102.
18. Kawahara, Y., Ito, K., Sun, H., Aizawa, H., Kanazawa, I. & Kwak, S. (2004) Glutamate receptors: RNA editing and death of motor neurons. Nature, 427, 801.
19. Krieger, C., Perry, T.L., Hansen, S., Mitsumoto, H. & Honore, T. (1992) Excitatory amino acid receptor antagonist in murine motoneuron disease (the wobbler mouse). Can. J. Neurol. Sci., 19, 462-465.
20. Lacomblez, L., Bensimon, G., Leigh, P.N., Guillet, P. & Meininger, V. (1996) Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II. Lancet, 347, 1425-1431.
21. Lipton, S.A. & Rosenberg, P.A. (1994) Mechanisms of disease: Excitatory amino acids as a final common pathway for neurologic disorders. N. Engl. J. Med., 330, 613-622.
22. MacLean, J.N., Schmidt, B.J. & Hochman, S. (1997) NMDA receptor activation triggers voltage oscillations, plateau potentials and bursting in neonatal rat lumbar motoneurons in vitro. Eur. J. Neurosci., 9, 2702-2711.
23. Michikawa, M., Lim, K.T., McLarnon, J.G. & Kim, S.U. (1994) Oxygen radical-induced neurotoxicity in spinal cord neuron cultures. J. Neurosci. Res., 37, 62-70.
24. Miguel-Hidalgo, J.J., Alvarez, X.A., Cacabelos, R. & Quack, G. (2002) Neuroprotection by memantine against neurodegeneration induced by beta-amyloid (1-40). Brain Res., 958, 210-221.
25. Regan, R.F. & Choi, D.W. (1991) Glutamate neurotoxicity in spinal cord cell culture. Neuroscience, 43, 585-591.
26. Reisberg, B., Doody, R., Stoffler, A., Schmitt, F., Ferris, S. & Mobius, H.J. (2003) Memantine in moderate-to-severe Alzheimer's disease. N. Engl. J. Med.,348, 1333-1341.
27. Rothstein, J.D. (1995) Excitotoxic mechanisms in the pathogenesis of amyotrophic lateral sclerosis. Adv. Neurol., 68, 7-20.
28. Rothstein, J.D., Martin, L.J. & Kuncl, R.W. (1992) Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis [see comments]. N. Engl. J. Med., 326, 1464-1468.
29. Rowland, L.P. & Shneider, N.A. (2001) Amyotrophic lateral sclerosis. N. Engl. J. Med., 344, 1688-1700.
30. Shaw, P.J. & Ince, P.G. (1997) Glutamate, excitotoxicity and amyotrophic lateral sclerosis. J. Neurol., 244, S3-S14.
31. Shibata, T., Watanabe, M., Ichikawa, R., Inoue, Y. & Koyanagi, T. (1999) Different expressions of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid and N-methyl-D-aspartate receptor subunit mRNAs between visceromotor and somatomotor neurons of the rat lumbosacral spinal cord. J. Comp. Neurol., 404, 172-182.
32. Spalloni, A., Albo, F., Ferrari, F., Mercuri, N., Bernardi, G., Zona, C. & Longone, P. (2004) Cu/Zn-superoxide dismutase (GLY93 → ALA) mutation alters AMPA receptor subunit expression and function and potentiates kainate-mediated toxicity in motor neurons in culture. Neurobiol. Dis., 15, 340-350.
33. Tariot, P.N., Farlow, M.R., Grossberg, G.T., Graham, S.M., McDonald, S. & Gergel, I. (2004) Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial. JAMA, 291, 317-324.
34. Tolle, T.R., Berthele, A., Zieglgansberger, W., Seeburg, P.H. & Wisden, W. (1993) The differential expression of 16 NMDA and non-NMDA receptor subunits in the rat spinal cord and in periaqueductal gray. J. Neurosci., 13, 5009-5028.
35. Trotti, D., Rolfs, A., Danbolt, N.C., Brown, R.H. & Hediger, M.A. (1999) SOD1 mutants linked to amyotrophic lateral sclerosis selectively inactivate a glial glutamate transporter. Nat. Neurosci., 2, 427-433.
36. Urushitani, M., Nakamizo, T., Inoue, R., Sawada, H., Kihara, T., Honda, K., Akaike, A. & Shimohama, S. (2001) N-methyl-D-aspartate receptor-mediated mitochondrial Ca (2+) overload in acute excitotoxic motor neuron death: a mechanism distinct from chronic neurotoxicity after Ca (2+) influx. J. Neurosci. Res., 63, 377-387.
37. Weller, M., Finiels-Marlier, F. & Paul, S.M. (1993) NMDA receptor-mediated glutamate toxicity of cultured cerebellar, cortical and mesencephalic neurons: neuroprotective properties of amantadine and memantine. Brain Res., 613, 143-148.
38. Wenk, G.L., Danysz, W. & Mobley, S.L. (1995) MK-801, memantine and amantadine show neuroprotective activity in the nucleus basalis magnocellularis. Eur. J. Pharmacol., 293, 267-270.
39. Wenk, G.L., Zajaczkowski, W. & Danysz, W. (1997) Neuroprotection of acetylcholinergic basal forebrain neurons by memantine and neurokinin B. Behav. Brain Res., 83, 129-133.
40. Wong, P.C., Pardo, C.A., Borchelt, D.R., Lee, M.K., Copeland, N.G., Jenkins, N.A., Sisodia, S.S., Cleveland, D.W. & Price, D.L. (1995) An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron, 14, 1105-1116.